5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 9.10▲ | 9.30▲ |
MA10 | N/A | N/A | N/A | 8.80▲ | 9.95▼ |
MA20 | N/A | N/A | N/A | 9.40▲ | 10.58▼ |
MA50 | N/A | N/A | N/A | 10.25▼ | 11.48▼ |
MA100 | N/A | N/A | N/A | 10.34▼ | 15.64▼ |
MA200 | N/A | N/A | N/A | 11.60▼ | 14.10▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.092▲ | -0.142▼ |
RSI | N/A | N/A | N/A | 47.975▼ | 42.622▼ |
STOCH | N/A | N/A | N/A | 57.220 | 27.121 |
WILL %R | N/A | N/A | N/A | -21.739▲ | -74.194 |
CCI | N/A | N/A | N/A | 42.860 | -46.691 |
CDL | $LAS.L Doji Candlestick Pattern Detected | Set Alert |
Thursday, March 28, 2024 05:45 AM
This positive trend should continue for DraftKings as its number of users continues to grow. At the end of 2023, it had 7.1 million unique customers, which was 1.1 million more than at the end of 2023 ...
|
Wednesday, March 27, 2024 06:02 AM
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...
|
Monday, March 25, 2024 07:53 AM
Ultomiris (ravulizumab-cwvz) has gained approval from the FDA as the inaugural long-acting C5 complement inhibitor for treating adult patients wi ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
27/03/24 | 9.50 | 9.50 | 9.50 | 9.50 | 1,000 |
26/03/24 | 9.50 | 9.94 | 9.50 | 9.50 | 15,000 |
25/03/24 | 9.50 | 9.50 | 9.50 | 9.50 | 15,000 |
22/03/24 | 8.50 | 8.50 | 8.50 | 8.50 | 100,000 |
21/03/24 | 8.50 | 8.8975 | 7.8333 | 8.50 | 26,360 |
20/03/24 | 8.50 | 8.50 | 8.50 | 8.50 | 26,360 |
19/03/24 | 8.50 | 8.50 | 7.75 | 8.50 | 5,204 |
18/03/24 | 8.50 | 8.50 | 8.50 | 8.50 | 5,204 |
15/03/24 | 8.50 | 8.50 | 7.70 | 8.50 | 100,000 |
14/03/24 | 8.50 | 8.50 | 8.50 | 8.50 | 27,000 |
|
|
||||
|
|
||||
|
|